Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy

Clinical trial NCT00239330 · COMPLETED

Trial details

NCT number: NCT00239330
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypercholesteremia

Start date: 2003-06-01
Primary completion: 2005-02-01
Enrollment: 824

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.